Nc1ccc(C(=O)N/C(=C\C=C\c2ccco2)c2nc3c4c(ccc3[nH]2)C(=O)c2ccccc2C4=O)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?